Published online before print July 18, 2005, doi: 10.1161/CIRCULATIONAHA.105.537340
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:513-520.)
© 2005 American Heart Association, Inc.
Genetics |
Mutations in Transforming Growth Factor-ß Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections
From the Department of Internal Medicine and Institute of Molecular Medicine (H.P., V.T.F., J.C., S.N.H., D.M.M.), the Department of Cardiothoracic and Vascular Surgery (A.L.E., H.J.S.), and the Structural Biology Research Center (C.S.R.), the University of Texas Health Science Center at Houston; the Department of Internal Medicine (E.S.), Cardiology Division, The Ohio State University, Columbus; the Department of Medical Genetic Services (P.F.G., C.Z.), Marshfield Clinic, Marshfield, Wis; the Department of Epidemiology (S.S.), the University of Texas M.D. Anderson Cancer Center, Houston, Tex; and the Department of Pediatrics, the University of Iowa (M.C.W.), Iowa City.
Correspondence to Dr Dianna Milewicz, 6431 Fannin, MSB 4.202, Houston, TX 77030. E-mail Dianna.M.Milewicz{at}uth.tmc.edu
Received December 8, 2004; de novo received January 19, 2005; revision received April 12, 2005; accepted April 18, 2005.
Background— A genetic predisposition for progressive enlargement of thoracic aortic aneurysms leading to type A dissection (TAAD) is inherited in an autosomal-dominant manner in up to 19% of patients, and a number of chromosomal loci have been identified for the condition. Having mapped a TAAD locus to 3p24–25, we sequenced the gene for transforming growth factor-ß receptor type II (TGFBR2) to determine whether mutations in this gene resulted in familial TAAD.
Methods and Results— We sequenced all 8 coding exons of TGFBR2 by using genomic DNA from 80 unrelated familial TAAD cases. We found TGFBR2 mutations in 4 unrelated families with familial TAAD who did not have Marfan syndrome. Affected family members also had descending aortic disease and aneurysms of other arteries. Strikingly, all 4 mutations affected an arginine residue at position 460 in the intracellular domain, suggesting a mutation "hot spot" for familial TAAD. Despite identical mutations in the families, assessment of linked polymorphisms suggested that these families were not distantly related. Structural analysis of the TGFBR2 serine/threonine kinase domain revealed that R460 is strategically located within a highly conserved region of this domain and that the amino acid substitutions resulting from these mutations will interfere with the receptor’s ability to transduce signals.
Conclusion— Germline TGFBR2 mutations are responsible for the inherited predisposition to familial TAAD in 5% of these cases. Our results have broad implications for understanding the role of TGF-ß signaling in the pathophysiology of TAAD.
Key Words: aneurysm • aorta • genetics • dissection • receptors, transforming growth factor beta
This article has been cited by other articles:
 |
|
 |
|
  V Tran-Fadulu, H Pannu, D H Kim, G W Vick III, C M Lonsford, A L Lafont, C Boccalandro, S Smart, K L Peterson, J Z. Hain, et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations J. Med. Genet., September 1, 2009; 46(9): 607 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Belville, J.-D. Marechal, S. Pennetier, P. Carmillo, L. Masgrau, L. Messika-Zeitoun, J. Galey, G. Machado, D. Treton, J. Gonzales, et al. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport Hum. Mol. Genet., August 15, 2009; 18(16): 3002 - 3013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Silberbach Bicuspid aortic valve and thoracic aortic aneurysm: toward a unified theory. J. Am. Coll. Cardiol., June 16, 2009; 53(24): 2296 - 2297. [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Caglayan and M. Dundar Inherited diseases and syndromes leading to aortic aneurysms and dissections Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 931 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Santiago-Sim, S. Mathew-Joseph, H. Pannu, D. M. Milewicz, C. E. Seidman, J.G. Seidman, and D. H. Kim Sequencing of TGF-{beta} Pathway Genes in Familial Cases of Intracranial Aneurysm Stroke, May 1, 2009; 40(5): 1604 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Cheng, T. Kikuchi, Y.-H. Chen, N. G. A.-A.-A. Sabbagha, Y.-C. Lee, H.-J. Pan, C. Chang, and Y.-T. Chen Mutations in the SLC2A10 gene cause arterial abnormalities in mice Cardiovasc Res, February 1, 2009; 81(2): 381 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Ruddy, J. A. Jones, F. G. Spinale, and J. S. Ikonomidis Regional heterogeneity within the aorta: Relevance to aneurysm disease. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1123 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. He, D.-C. Guo, W. Sun, C. L. Papke, S. Duraisamy, A. L. Estrera, H. J. Safi, C. Ahn, L. Maximilian Buja, F. C. Arnett, et al. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 922 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Pearson, R. Devereux, B. Loeys, C. Maslen, D. Milewicz, R. Pyeritz, F. Ramirez, D. Rifkin, L. Sakai, L. Svensson, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders Circulation, August 12, 2008; 118(7): 785 - 791. [Full Text] [PDF]
|
|
|
|
 |
|
 Y M Ruigrok, S Tan, J Medic, G J E Rinkel, and C Wijmenga Genes involved in the transforming growth factor beta signalling pathway and the risk of intracranial aneurysms J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 722 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Faivre, G Collod-Beroud, A Child, B Callewaert, B L Loeys, C Binquet, E Gautier, E Arbustini, K Mayer, M Arslan-Kirchner, et al. Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands J. Med. Genet., June 1, 2008; 45(6): 384 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Touat, L. Lepage, V. Ollivier, P. Nataf, U. Hvass, J. Labreuche, M. Jandrot-Perrus, J.-B. Michel, and G. Jondeau Dilation-Dependent Activation of Platelets and Prothrombin in Human Thoracic Ascending Aortic Aneurysm Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 940 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Alhopuro, D. Phichith, S. Tuupanen, H. Sammalkorpi, M. Nybondas, J. Saharinen, J. P. Robinson, Z. Yang, L.-Q. Chen, T. Orntoft, et al. Unregulated smooth-muscle myosin in human intestinal neoplasia PNAS, April 8, 2008; 105(14): 5513 - 5518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kuivaniemi, C. D. Platsoucas, and M. D. Tilson III Aortic Aneurysms: An Immune Disease With a Strong Genetic Component Circulation, January 15, 2008; 117(2): 242 - 252. [Full Text] [PDF]
|
|
|
|
|
|
H. Pannu, V. Tran-Fadulu, C. L. Papke, S. Scherer, Y. Liu, C. Presley, D. Guo, A. L. Estrera, H. J. Safi, A. R. Brasier, et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II Hum. Mol. Genet., October 15, 2007; 16(20): 2453 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Waldmuller, M. Muller, H. Warnecke, W. Rees, W. Schols, G. Walterbusch, J. Ennker, and T. Scheffold Genetic testing in patients with aortic aneurysms/dissections: a novel genotype/phenotype correlation? Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 970 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. von Kodolitsch and P. N Robinson Marfan syndrome: an update of genetics, medical and surgical management Heart, June 1, 2007; 93(6): 755 - 760. [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Heegaard, A. Corsi, C. C. Danielsen, K. L. Nielsen, H. L. Jorgensen, M. Riminucci, M. F. Young, and P. Bianco Biglycan Deficiency Causes Spontaneous Aortic Dissection and Rupture in Mice Circulation, May 29, 2007; 115(21): 2731 - 2738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Albornoz, M. A. Coady, M. Roberts, R. R. Davies, M. Tranquilli, J. A. Rizzo, and J. A. Elefteriades Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns. Ann. Thorac. Surg., October 1, 2006; 82(4): 1400 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P N Robinson, E Arteaga-Solis, C Baldock, G Collod-Beroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, et al. The molecular genetics of Marfan syndrome and related disorders J. Med. Genet., October 1, 2006; 43(10): 769 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Loeys, U. Schwarze, T. Holm, B. L. Callewaert, G. H. Thomas, H. Pannu, J. F. De Backer, G. L. Oswald, S. Symoens, S. Manouvrier, et al. Aneurysm Syndromes Caused by Mutations in the TGF-{beta} Receptor N. Engl. J. Med., August 24, 2006; 355(8): 788 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Gelb Marfan's Syndrome and Related Disorders -- More Tightly Connected Than We Thought N. Engl. J. Med., August 24, 2006; 355(8): 841 - 844. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Ikonomidis, J. A. Jones, J. R. Barbour, R. E. Stroud, L. L. Clark, B. S. Kaplan, A. Zeeshan, J. E. Bavaria, J. H. Gorman III, F. G. Spinale, et al. Expression of Matrix Metalloproteinases and Endogenous Inhibitors Within Ascending Aortic Aneurysms of Patients With Marfan Syndrome Circulation, July 4, 2006; 114(1_suppl): I-365 - I-370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Poon, F. Clermont, M. T. Firpo, and R. J. Akhurst TGF{beta} inhibition of yolk-sac-like differentiation of human embryonic stem-cell-derived embryoid bodies illustrates differences between early mouse and human development J. Cell Sci., February 15, 2006; 119(4): 759 - 768. [Abstract] [Full Text] [PDF]
|
|